{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,18]],"date-time":"2026-10-18T02:39:32Z","timestamp":1792291172523,"version":"4.4.0"},"reference-count":18,"publisher":"Oxford University Press (OUP)","issue":"3","license":[{"start":{"date-parts":[[2020,1,21]],"date-time":"2020-01-21T00:00:00Z","timestamp":1579564800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2020,3,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title\/>\n                  <jats:p>The European Heart Rhythm Association (EHRA) and European Renal Association\/European Dialysis and Transplantation Association (ERA\/EDTA) jointly conducted a physician-based survey to gain insight into the management of atrial fibrillation (AF) in patients with chronic kidney disease (CKD) and adherence to current European Society of Cardiology AF Guidelines in contemporary clinical practice. Physician-based survey conducted during an 8-week period using an internet-based questionnaire sent to all EHRA and ERA\/EDTA members, with voluntary and anonymous responses. Among 306 physicians (160 EHRA and 146 ERA\/EDTA members; 56 countries), a multidisciplinary team for management of AF-CKD patients was available to only 20\/300 respondents (6.7%) and 132\/295 (44.7%) routinely screened CKD patients for AF. Oral anticoagulation (OAC) use was based on individual stroke risk in mild\/moderate CKD but on shared decision-making in advanced CKD. The CHA2DS2-VASc score-based decisions were more common among cardiologists, with substantial intra- and inter-specialty heterogeneity in the use and dosing of specific OAC drugs across CKD stages, heterogeneous strategies for OAC monitoring (especially among nephrologists) and a modest impact of CKD on rate and rhythm control treatment decisions. The HAS-BLED score was generally not a determinant of OAC prescribing. Our survey provided important insights into contemporary management of AF patients with CKD in clinical practice, revealing certain differences between nephrologists and cardiologists and highlighting shared and specific knowledge gaps and unmet needs. These findings emphasize the need for streamlining the care for AF patients across different specialties and may inform development of tailored education interventions.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1093\/europace\/euz358","type":"journal-article","created":{"date-parts":[[2019,12,13]],"date-time":"2019-12-13T12:11:41Z","timestamp":1576239101000},"page":"496-505","source":"Crossref","is-referenced-by-count":48,"title":["Management of atrial fibrillation in patients with chronic kidney disease in clinical practice: a joint European Heart Rhythm Association (EHRA) and European Renal Association\/European Dialysis and Transplantation Association (ERA\/EDTA) physician-based survey"],"prefix":"10.1093","volume":"22","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6285-6902","authenticated-orcid":false,"given":"Tatjana S","family":"Potpara","sequence":"first","affiliation":[{"name":"School of Medicine, Belgrade University, Visegradska 26, 11000 Belgrade, Serbia"},{"name":"Cardiology Clinic, Clinical Centre of Serbia, Belgrade, Serbia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charles","family":"Ferro","sequence":"first","affiliation":[{"name":"Department of Renal Medicine, University Hospitals Birmingham, Edgbaston, Birmingham, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gregory Y H","family":"Lip","sequence":"first","affiliation":[{"name":"Liverpool Centre for Cardiovascular Science, Liverpool Heart & Chest Hospital, University of Liverpool, Liverpool, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"George A","family":"Dan","sequence":"first","affiliation":[{"name":"Medicine University \u2018Carol Davila\u2019, Colentina University Hospital, Bucharest, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Radoslaw","family":"Lenarczyk","sequence":"first","affiliation":[{"name":"First Department of Cardiology and Angiology, Silesian Centre for Heart Disease, Curie-Sklodowskiej Str 9, 41-800 Zabrze, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesca","family":"Mallamaci","sequence":"first","affiliation":[{"name":"CNR-IFC, Clinical Epidemiology and Pathophysiology of Hypertension and Renal Diseases, Ospedali Riuniti, 89124 Reggio Calabria, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alberto","family":"Ortiz","sequence":"first","affiliation":[{"name":"IIS-Fundacion Jimenez Diaz, School of Medicine, University Autonoma of Madrid, FRIAT and REDINREN, Madrid, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pantelis","family":"Sarafidis","sequence":"first","affiliation":[{"name":"Department of Nephrology, Hippokration Hospital, Aristotle University of Thessaloniki, Thessaloniki, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Ekart","sequence":"first","affiliation":[{"name":"Faculty of Medicine, Maribor University, Maribor, Slovenia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0323-4956","authenticated-orcid":false,"given":"Nikolaos","family":"Dagres","sequence":"first","affiliation":[{"name":"Department of Electrophysiology, Heart Center Leipzig, Leipzig, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2020,1,21]]},"reference":[{"key":"2020030603532688700_euz358-B1","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1038\/nrneph.2018.19","article-title":"Use of oral anticoagulants in patients with atrial fibrillation and renal dysfunction","volume":"14","author":"Potpara","year":"2018","journal-title":"Nat Rev Nephrol"},{"key":"2020030603532688700_euz358-B2","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1093\/europace\/euv202","article-title":"Chronic kidney disease in patients with cardiac rhythm disturbances or implantable electrical devices: clinical significance and implications for decision making\u2014a position paper of the European Heart Rhythm Association endorsed by the Heart Rhythm Society and the Asia Pacific Heart Rhythm Society","volume":"17","author":"Boriani","year":"2015","journal-title":"Europace"},{"key":"2020030603532688700_euz358-B3","doi-asserted-by":"crossref","first-page":"1230","DOI":"10.1160\/TH16-11-0876","article-title":"Stroke prevention in atrial fibrillation: past, present and future","volume":"117","author":"Lip","year":"2017","journal-title":"Thromb Haemost"},{"key":"2020030603532688700_euz358-B4","doi-asserted-by":"crossref","first-page":"2055","DOI":"10.2174\/0929867323666160210130109","article-title":"Non-vitamin K oral anticoagulant drugs for stroke prevention in patients with atrial fibrillation and chronic kidney disease","volume":"23","author":"Potpara","year":"2016","journal-title":"Curr Med Chem"},{"key":"2020030603532688700_euz358-B5","doi-asserted-by":"crossref","first-page":"1919","DOI":"10.1093\/europace\/euy039","article-title":"Major knowledge gaps and system barriers to guideline implementation among European physicians treating patients with atrial fibrillation: a European Society of Cardiology international educational needs assessment","volume":"20","author":"Heidbuchel","year":"2018","journal-title":"Europace"},{"key":"2020030603532688700_euz358-B6","doi-asserted-by":"crossref","first-page":"e012656.","DOI":"10.1161\/JAHA.119.012656","article-title":"Impact of a multidisciplinary treatment pathway for atrial fibrillation in the emergency department on hospital admissions and length of stay: results of a multi-center study","volume":"8","author":"Ptaszek","year":"2019","journal-title":"J Am Heart Assoc"},{"key":"2020030603532688700_euz358-B7","first-page":"1947","article-title":"Integrated care in atrial fibrillation: a systematic review and meta-analysis","volume":"103","author":"Gallagher","year":"2017","journal-title":"Heart"},{"key":"2020030603532688700_euz358-B8","doi-asserted-by":"crossref","first-page":"1609","DOI":"10.1093\/europace\/euw295","article-title":"2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS","volume":"18","author":"Kirchhof","year":"2016","journal-title":"Europace"},{"key":"2020030603532688700_euz358-B9","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1093\/europace\/eux301","article-title":"Contemporary stroke prevention strategies in 11 096 European patients with atrial fibrillation: a report from the EURObservational Research Programme on Atrial Fibrillation (EORP-AF) Long-Term General Registry","volume":"20","author":"Boriani","year":"2018","journal-title":"Europace"},{"key":"2020030603532688700_euz358-B10","doi-asserted-by":"crossref","first-page":"20432.","DOI":"10.1038\/srep20432","article-title":"Stroke prevention in atrial fibrillation and \u2018real world\u2019 adherence to guidelines in the Balkan Region: the BALKAN-AF Survey","volume":"6","author":"Potpara","year":"2016","journal-title":"Sci Rep"},{"key":"2020030603532688700_euz358-B11","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1016\/j.chest.2018.07.040","article-title":"Antithrombotic therapy for atrial fibrillation: CHEST Guideline and Expert Panel Report","volume":"154","author":"Lip","year":"2018","journal-title":"Chest"},{"key":"2020030603532688700_euz358-B12","doi-asserted-by":"crossref","first-page":"1862","DOI":"10.1093\/europace\/euv416","article-title":"Management of atrial fibrillation in patients with chronic kidney disease in Europe Results of the European Heart Rhythm Association Survey","volume":"17","author":"Potpara","year":"2015","journal-title":"Europace"},{"key":"2020030603532688700_euz358-B13","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1016\/S0140-6736(13)62343-0","article-title":"Comparison of the efficacy and safety of new oral anticoagulants with warfarin in patients with atrial fibrillation: a meta-analysis of randomised trials","volume":"383","author":"Ruff","year":"2014","journal-title":"Lancet"},{"key":"2020030603532688700_euz358-B14","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1093\/europace\/euy054","article-title":"The 2018 European Heart Rhythm Association Practical Guide on the use of non-vitamin K antagonist oral anticoagulants in patients with atrial fibrillation: executive summary","volume":"20","author":"Steffel","year":"2018","journal-title":"Europace"},{"key":"2020030603532688700_euz358-B15","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1016\/j.cjca.2017.02.004","article-title":"Warfarin and the risk of stroke and bleeding in patients with atrial fibrillation receiving dialysis: a systematic review and meta-analysis","volume":"33","author":"Harel","year":"2017","journal-title":"Can J Cardiol"},{"key":"2020030603532688700_euz358-B16","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.1161\/CIRCULATIONAHA.118.035418","article-title":"Outcomes associated with apixaban use in patients with end-stage kidney disease and atrial fibrillation in the United States","volume":"138","author":"Siontis","year":"2018","journal-title":"Circulation"},{"key":"2020030603532688700_euz358-B17","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1016\/j.amjmed.2019.04.013","article-title":"Rivaroxaban versus warfarin in patients with nonvalvular atrial fibrillation and severe kidney disease or undergoing hemodialysis","volume":"132","author":"Coleman","year":"2019","journal-title":"Am J Med"},{"key":"2020030603532688700_euz358-B18","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.1016\/j.amjmed.2016.08.019","article-title":"Creatinine clearance is not equal to glomerular filtration rate and Cockcroft-Gault equation is not equal to CKD-EPI collaboration equation","volume":"129","author":"Fernandez-Prado","year":"2016","journal-title":"Am J Med"}],"container-title":["EP Europace"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/europace\/article-pdf\/22\/3\/496\/32793718\/euz358.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/europace\/article-pdf\/22\/3\/496\/32793718\/euz358.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,3,6]],"date-time":"2020-03-06T08:53:47Z","timestamp":1583484827000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/europace\/article\/22\/3\/496\/5712974"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,1,21]]},"references-count":18,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2020,1,21]]},"published-print":{"date-parts":[[2020,3,1]]}},"URL":"https:\/\/doi.org\/10.1093\/europace\/euz358","relation":{},"ISSN":["1099-5129","1532-2092"],"issn-type":[{"value":"1099-5129","type":"print"},{"value":"1532-2092","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2020,3]]},"published":{"date-parts":[[2020,1,21]]}}}